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Cryoglobulins are immunogloblulins that persist in the serum, precipitate with cold temperature, and resolubilize when rewarmed. Mixed cryoglobulins, composed of different immunoglobulins, with a monoclonal component in type II and only polyclonal immunoglobulins in type III, are associated with connective tissue, malignant hematologic, or obvious infectious diseases. The syndrome of mixed cryoglobulinemia represents the consequence of an immune complex-type vasculitis. It is characterized by the clinical triad of purpura, arthralgia, and asthenia, and may involve numerous organs, particularly the peripheral nervous system and the kidneys. Mixed cryoglobulinemia frequently is associated with clinical and biologic evidence of liver disease. It seems fairly clear that mixed cryoglobulinemia is often a manifestation of underlying chronic active or persistent hepatitis. In the last 10 years, many studies have demonstrated that infection with hepatitis C virus is involved in the pathogenesis of most mixed cryoglobulinemia vasculitis. This review analyzes the main published data of hepatitis C virus-mixed cryoglobulinemia, the role of liver alterations, the predictive factors associated with mixed cryoglobulin production in hepatitis C virus patients and whether its character is symptomatic, and the different types of vasculitis associated with hepatitis C virus chronic infection and their treatments. Cryoglobulinemia and syndrome of mixed cryoglobulinemia before the era of hepatitis C virus Cryoglobulins Clinical and biologic evidence of liver disease was found in 60 to 80% of patients with essential mixed cryoglobulinemia whose liver biopsies showed chronic active hepatitis or cirrhosis [5] [6] [7] . Cryoglobulins are sought in 6 to 43% of patients with chronic liver disease [7, 8] . In mixed cryoglobulinemia patients, the hepatotropic antigen triggering the production of antibodies that later can form immune complexes has been sought for many years. Levo et al. [9] first implicated hepatitis B virus (HBV) as a causative agent of essential mixed cryoglobulinemia, and subsequent studies claimed a high prevalence of HBV surface markers in both sera and cryoprecipitates of patients with essential mixed cryoglobulinemia. Numerous studies using more recent tests for the detection of HBV surface markers and HBV DNA failed to validate these observations [ [14] , the authors found anti-HCV antibody in 33 (52%) of 63 patients with essential mixed cryoglobulinemia. The 33 anti-HCV antibody-positive patients had more cutaneous involvement (Raynaud phenomenon, purpura, livedo, distal ulcers, or gangrenous changes), higher alanine aminotransferase, higher serum cryoglobulin, and lower CH50 and C4 levels.
Role of liver alterations
Whether mixed cryoglobulinemia was the cause or the consequence of the liver disease was unclear in old studies. The immune complexes present in a large proportion of patients with mixed cryoglobulinemia could cause liver alterations through the activation of Kupffer cells. Table 2) . Cirrhosis was more frequent, serum albumin level was lower, and gammaglobulin level was higher in patients with mixed cryoglobulinemia, suggesting that severity or duration of liver disease may play a role in the pathogenesis of cryoglobulinemia [34•].
Hepatitis C virus is involved in mixed cryoglobulinemia pathogenesis
From a clinical point of view, anti-HCV antibodypositive patients with mixed cryoglobulinemia have cryoglobulin-related manifestations more often than anti-HCV antibody-negative patients. There is a twofold to threefold increased frequency of mixed cryoglobulinemia in HCV chronic hepatitis compared with HBV or non-A, non-B, non-C chronic liver disease [10,14,32,33, 34•]. Mixed cryoglobulinemia and HCV infection are relatively uncommon in northern Europe and North America, but are more common in southern Europe [38] . A possible explanation for the HCV-mixed cryoglobuli- [65] . By univariate and multivariate analysis, HLA-DR11 was the only positive predictive factor for the presence of mixed cryoglobulinemia and HCV-mixed cryoglobulinemiaassociated vasculitis. HLA-DR7 appears to protect from the production of type II mixed cryoglobulins. These results suggest that the host's immune response genes may play a role in the pathogenesis of HCV-mixed cryoglobulinemia.
Types of vasculitis associated with hepatitis C virus chronic infection
Mixed cryoglobulinemia, an immune complex-type vasculitis, preferentially involves small vessels (ie, venules, capillaries, arterioles). [73] [74] [75] . A necrotizing vasculitis associated with HCV infection has been treated successfully with interferon ␣ despite the persistence of mixed cryoglobulins [76] . All patients with HCV-polyarteritis nodosa-type vasculitis were examined for very severe acute clinical manifestations, with numerous organ failure often life-threatening [77] . Patients with HCV-mixed cryoglobulinemiaassociated vasculitis mainly showed subacute moderate skin and peripheral neurologic symptoms [78] [79] [80] . Some features found in patients with HCV with polyarteritis nodosa vasculitis have not been reported in mixed cryoglobulinemia, such as microaneurysms [81] and renal cortical necrosis secondary to occlusion of medium-size arteries. Antineutrophil cytoplasmic antibodies are not helpful in the distinction between polyarteritis nodosa and HCV-mixed cryoglobulinemia-type vasculitis because they are rarely found in either [77] [78] [79] [80] [81] [82] . Classic polyarteritis nodosa involves medium-size and small-size vessels with a mixed inflammatory infiltrate of mono- 
